140 related articles for article (PubMed ID: 38322649)
1. Computational identification of candidate inhibitors for Dihydrofolate reductase in
Bhati SK; Jain M; Muthukumaran J; Singh AK
Curr Res Struct Biol; 2024; 7():100127. PubMed ID: 38322649
[No Abstract] [Full Text] [Related]
2. Identification of promising molecules against MurD ligase from Acinetobacter baumannii: insights from comparative protein modelling, virtual screening, molecular dynamics simulations and MM/PBSA analysis.
Jha RK; Khan RJ; Amera GM; Singh E; Pathak A; Jain M; Muthukumaran J; Singh AK
J Mol Model; 2020 Oct; 26(11):304. PubMed ID: 33068184
[TBL] [Abstract][Full Text] [Related]
3. Structural and functional characterization of 1-deoxy-D-xylulose-5-phosphate synthase (DXS) from
Parveez Zia M; Singh E; Jain M; Muthukumaran J; Singh AK
J Biomol Struct Dyn; 2023; 41(21):11598-11611. PubMed ID: 36752319
[TBL] [Abstract][Full Text] [Related]
4. Structure based drug designing and discovery of promising lead molecules against UDP-N-acetylenolpyruvoylglucosamine reductase (MurB): A potential drug target in multi-drug resistant Acinetobacter baumannii.
Amera GM; Khan RJ; Pathak A; Jha RK; Jain M; Muthukumaran J; Singh AK
J Mol Graph Model; 2020 Nov; 100():107675. PubMed ID: 32731183
[TBL] [Abstract][Full Text] [Related]
5. An extensive computational study to identify potential inhibitors of Acyl-homoserine-lactone synthase from Acinetobacter baumannii (strain AYE).
Jha RK; Jabeer Khan R; Singh E; Kumar A; Jain M; Muthukumaran J; Singh AK
J Mol Graph Model; 2022 Jul; 114():108168. PubMed ID: 35339024
[TBL] [Abstract][Full Text] [Related]
6. Identification and prioritization of potential therapeutic molecules against LpxA from
Khan RJ; Singh E; Jha RK; Kumar A; Bhati SK; Zia MP; Jain M; Singh RP; Muthukumaran J; Singh AK
Curr Res Struct Biol; 2023; 5():100096. PubMed ID: 36895415
[TBL] [Abstract][Full Text] [Related]
7. In Silico Study Identified Methotrexate Analog as Potential Inhibitor of Drug Resistant Human Dihydrofolate Reductase for Cancer Therapeutics.
Rana RM; Rampogu S; Abid NB; Zeb A; Parate S; Lee G; Yoon S; Kim Y; Kim D; Lee KW
Molecules; 2020 Jul; 25(15):. PubMed ID: 32752079
[TBL] [Abstract][Full Text] [Related]
8. Targeting multi-drug-resistant Acinetobacter baumannii: a structure-based approach to identify the promising lead candidates against glutamate racemase.
Kumar A; Singh E; Jha RK; Khan RJ; Jain M; Varshney S; Muthukumaran J; Singh AK
J Mol Model; 2023 May; 29(6):188. PubMed ID: 37225922
[TBL] [Abstract][Full Text] [Related]
9. In silico high-throughput virtual screening and molecular dynamics simulation study to identify inhibitor for AdeABC efflux pump of Acinetobacter baumannii.
Verma P; Tiwari M; Tiwari V
J Biomol Struct Dyn; 2018 Apr; 36(5):1182-1194. PubMed ID: 28393677
[TBL] [Abstract][Full Text] [Related]
10. Droperidol as a potential inhibitor of acyl-homoserine lactone synthase from A. baumannii: insights from virtual screening, MD simulations and MM/PBSA calculations.
Jha RK; Singh E; Khan RJ; Kumar A; Jain M; Muthukumaran J; Singh AK
Mol Divers; 2023 Oct; 27(5):1979-1999. PubMed ID: 36190592
[TBL] [Abstract][Full Text] [Related]
11. Structure-based identification of potential natural compound inhibitors targeting bacterial cytoskeleton protein FtsZ from
Roy Chowdhury S; Saha R; Koley T; Naz F; Sharma S; Khan MI; Kumar M; Kaur P; Ethayathulla AS
J Biomol Struct Dyn; 2024 Jan; ():1-13. PubMed ID: 38239064
[No Abstract] [Full Text] [Related]
12. Carboxymuconolactone decarboxylase is a prospective molecular target for multi-drug resistant Acinetobacter baumannii-computational modeling, molecular docking and dynamic simulation studies.
Rana S; Skariyachan S; Uttarkar A; Niranjan V
Comput Biol Med; 2023 May; 157():106793. PubMed ID: 36944292
[TBL] [Abstract][Full Text] [Related]
13. High throughput virtual screening and molecular dynamics simulation analysis of phytomolecules against BfmR of
Lokhande KB; Pawar SV; Madkaiker S; Nawani N; Venkateswara SK; Ghosh P
J Biomol Struct Dyn; 2023 Apr; 41(7):2698-2712. PubMed ID: 35156902
[No Abstract] [Full Text] [Related]
14. A computational perspective towards the identification of promising lead molecules against 6-hydroxy-methyl dihydropterin pyrophosphokinase (HPPK) from
Bhati SK; Jain M; Muthukumaran J; Singh AK
J Biomol Struct Dyn; 2023 Jul; ():1-10. PubMed ID: 37490027
[No Abstract] [Full Text] [Related]
15. The Anti-Multidrug-Resistant
Wu H; Chen H; Zhang J; Hu X; Xie C; Cao W; Zhao Z; Xiao Z; Ren Y; Dong L; Sun P; You X; Yang X; Hong W; Wang H
Molecules; 2022 Dec; 27(23):. PubMed ID: 36500701
[TBL] [Abstract][Full Text] [Related]
16. Increased substrate affinity in the Escherichia coli L28R dihydrofolate reductase mutant causes trimethoprim resistance.
Abdizadeh H; Tamer YT; Acar O; Toprak E; Atilgan AR; Atilgan C
Phys Chem Chem Phys; 2017 May; 19(18):11416-11428. PubMed ID: 28422217
[TBL] [Abstract][Full Text] [Related]
17. Computational Development of Inhibitors of Plasmid-Borne Bacterial Dihydrofolate Reductase.
Silva PJ
Antibiotics (Basel); 2022 Jun; 11(6):. PubMed ID: 35740185
[TBL] [Abstract][Full Text] [Related]
18. Structure-based identification of novel inhibitors targeting the enoyl-ACP reductase enzyme of Acinetobacter baumannii.
Khan S; Madhi SA; Olwagen C
Sci Rep; 2023 Dec; 13(1):21331. PubMed ID: 38044353
[TBL] [Abstract][Full Text] [Related]
19. Identification of putative non-host essential genes and novel drug targets against Acinetobacter baumannii by in silico comparative genome analysis.
Uddin R; Masood F; Azam SS; Wadood A
Microb Pathog; 2019 Mar; 128():28-35. PubMed ID: 30550846
[TBL] [Abstract][Full Text] [Related]
20. Diaminoquinazoline MMV675968 from Pathogen Box inhibits Acinetobacter baumannii growth through targeting of dihydrofolate reductase.
Songsungthong W; Yongkiettrakul S; Bohan LE; Nicholson ES; Prasopporn S; Chaiyen P; Leartsakulpanich U
Sci Rep; 2019 Oct; 9(1):15625. PubMed ID: 31666629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
